Novartis Investigative Site

Bucharest, Romania 050659

0 studies enrolling now · 3 studies all time

What they study most

Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction, Hepatitis C

Studies at this site

• Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure — Completed
• Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early